Table of Contents
ISRN Surgery
Volume 2012, Article ID 804891, 6 pages
http://dx.doi.org/10.5402/2012/804891
Clinical Study

Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer

1Department of Surgery, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK
2Department of Cellular Pathology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK
3Department of Surgery, Nevill Hall Hospital, Abergavenny NP7 7EG, UK
4Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XW, UK

Received 5 April 2012; Accepted 14 June 2012

Academic Editors: D. M. D'Ugo and G. A. Tiberio

Copyright © 2012 David S. Y. Chan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

David S. Y. Chan, Fiona Campbell, Paul Edwards, Bharat Jasani, Geraint T. Williams, and Wyn G. Lewis, “Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer,” ISRN Surgery, vol. 2012, Article ID 804891, 6 pages, 2012. https://doi.org/10.5402/2012/804891.